nmdp logo

Urgency Versus Optimization in the Treatment of AML

Pharmacological Advances and the Role of HCT

Release date: May 14, 2024

Live event: May 7, 2024

Access on-demand webinar*

*Note: If you’ve already registered for this webinar, click here. Otherwise, use the link above to register.

Program overview

During this webinar, our expert transplant and hematology/oncology speakers discuss implications for practice change in the pharmacological treatment of acute myeloid leukemia (AML) and optimal timing for hematopoietic cell transplantation (HCT), as well as ways to improve access to care. Sample patient cases illustrate key concepts through practical examples. 

This discussion is tailored for hematologists/oncologists who refer out for transplant and cell therapies as well as for transplant physicians to highlight the role of sharing care to improve patient access and outcomes. 

Interested in claiming CME credit?

Be sure to complete the pre-test here, then complete the post-evaluation after watching the webinar. The evaluation can be found in the on-demand webinar platform on the left-hand menu under (“Complete Evaluation”). For more information, see the instructions for participation and requesting credit below.

Target audience

This educational activity is intended for physicians, nurses and other members of the health care team who care for patients who may benefit from hematopoietic cell transplantation (HCT).

Learning objectives

Upon completion of this course, the learners should be able to:

  • Understand the latest treatment recommendations for AML and indications for HCT
  • Identify pharmacological advances in AML treatment and their effects on optimal HCT timing
  • Explore referral patterns and challenges in the management and treatment of AML
  • Describe advances in HCT that facilitate improved access and outcomes in care 
  • Elucidate the role of transplant and hematology/oncology physicians in optimizing pharmacological care and HCT for patients with AML

Faculty

Steven Devine, MD (moderator)
Chief Medical Officer
NMDPSM
Senior Scientific Director
CIBMTR®-NMDP

Rebecca Olin, MD, MSCE
Professor of Medicine
University of California San Francisco

Sarah Wall, MD, MPH
Director of Clinical Operations, Transplant and Cell Therapy Program
Assistant Professor
The Ohio State University

Planning committee

Anna Cincotta, FNP
Market Access Lead
Patient and Provider Services
NMDP

Samantha Watters, MPH
Research and Education Lead
Patient and Provider Services
NMDP

Instructions for participation and requesting credit

There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, attending the activity and completing the evaluation form.

Credit fulfillment

  • If you are requesting AMA credits, ANCC credits or a certificate of participation, your certificate will be available for download.

Technical requirements

This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox and Safari browsers.

Additionally, this site and its activities are best viewed using the latest Operating System for your device.

Accredited provider

This activity is jointly provided by The France Foundation and NMDP.

The France Foundation
nmdp logo

Accreditation Statement

Jointly Accredited Provider

In support of improving patient care, this activity has been planned and implemented by The France Foundation and NMDP. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.

Credit designation

PHYSICIANS

ACCME Accredited

The France Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES

ANCC

The France Foundation designates this activity for 1.0 contact hour.

All other health care professionals completing this course will be issued a statement of participation.

Disclosure policy

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) and NMDP require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF and NMDP resolve all conflicts of interest to ensure independence, objectivity, balance and scientific rigor in all their educational programs. Furthermore, TFF and NMDP verify that all scientific research referred to, reported or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection and analysis. TFF and NMDP are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Planning committee members, faculty, reviewers and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.

Name of individual Individual’s role in activity Name of commercial entity Nature of relationship(s) Mechanism(s) implemented to resolve conflict of interest
Anna Cincotta, FNP Planning Committee member, content reviewer No relevant financial disclosures N/A N/A
Ashley Smeaton, MHA TFF staff No relevant financial disclosures N/A N/A
Heather Tarbox, MPH TFF Staff No relevant financial disclosures N/A N/A
Rebecca Olin, MD, MSCE Faculty

1. Rigel, Servier

2. Cellectis

1. Non-CE Consulting

2. Contract Research

Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning.
Samantha Watters, MPH Planning Committee Member, NMDP Staff No relevant financial disclosures N/A N/A
Sarah Wall, MD, MPH Faculty

1. Bristol Myers Squibb, MorphoSys

2. Sobi Educational Speaker Bureau

1. Advisory Board

2. Non-CE Speakers Bureau

The following relationships were mitigated by:

  • Bristol Myers Squibb ending in December 2022
  • MorphoSys ending in December 2023

Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning.

Steven Devine, MD Faculty Moderator No relevant financial disclosures N/A N/A

Disclosure of unlabeled use

TFF and NMDP require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF and NMDP do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Media disclosure

Your registration, attendance at, and/or participation in this meeting constitutes consent to being photographed, videotaped or recorded during the meeting by The France Foundation, its educational collaborators or anyone authorized on behalf of these organizations. You further authorize, without any compensation paid to you, the use of any photographs, videos or recordings that contain your likeness, image or voice in any educational, informational, commercial or promotional materials produced and/or distributed by The France Foundation, its educational collaborators, or anyone authorized by these organizations, as well as on any internet sites maintained by any of these entities. Images/recordings used for these purposes will not be sold, and no personal information about you or the subject (other than event location and date) will be included in the production of any material.

Disclaimer

TFF and NMDP present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and NMDP and the commercial supporter(s) assume no liability for the information herein.

Contact information

If you have questions about this CME activity, please contact The France Foundation at 1 (860) 434-1650 or info@francefoundation.com.